For Amazon Subscribers’ Eyes Only #121

Editor: Christopher Brennan
The Everything Store has been everywhere, from Jeff Bezos’s departure as CEO of Amazon to antitrust suits to continued campaigns for better working conditions to the purchase of MGM, the studio behind James Bond and other titles, for more than $8 billion. This week we set our algorithm to pull together stories that touch on Amazon and add something to the conversation, scored with Deepnews quality scores.

This Too Shall Passport #120

Editor: Christopher Brennan
One of the first areas to suffer from the pandemic was the the interconnectedness of the world, with airport flight boards going empty as international travel was cut off. Over the past couple weeks countries faring well with their vaccination campaigns have begun looking at “vaccine passports,” and debating issues such as privacy, feasibility, where they should be used and where they shouldn’t. This week’s Digest includes well done reporting and analysis on all the angles on vaccine passports, as well as some in-depth articles on vaccines more generally. Gathered and rated with Deepnews quality scores.

Watch This (Office) Space #119

Editor: Christopher Brennan
Along with falling coronavirus rates in many countries come questions of when “normal” returns and what exactly we want “normal” to mean for our working lives. It’s a subject where many news outlets have written a piece or two, though it can be hard to get all the angles on the issue without something like Deepnews to spotlight reporting and analysis. Here is what our algorithm gathered this week on the subjects of working from home and the return to the office.

Giving Everyone a Shot #118

Editor: Christopher Brennan
As vaccine rollouts start to suppress the coronavirus in some countries, others are wondering when it will be their turn. With any global topic, such as patents, there is a lot to take in. Deepnews can be particularly useful in these sorts of media monitoring situations, as by focusing on quality it finds articles that are contributing to the conversation with reporting and analysis, rather than putting forward the same content as everyone else. Here is a selection on the subject of vaccines and vaccine patents.